Oral Glucocerebrosidase Activator Cuts α-Synuclein in Parkinson’s
In a groundbreaking advancement that could reshape the therapeutic landscape of Parkinson’s disease, researchers have revealed that a long-term oral ...
In a groundbreaking advancement that could reshape the therapeutic landscape of Parkinson’s disease, researchers have revealed that a long-term oral ...
In the intricate landscape of Parkinson’s disease research, a startling new dimension has emerged—one that implicates environmental noise as a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine